Episodes

Thursday Apr 30, 2020
Thursday Apr 30, 2020
This episode is shared from Mayo Clinic Q&A and was recorded on April 29, 2020
To claim credit visit: https://ce.mayo.edu/covid19podcast
Guest: Gregory A. Poland, M.D. (@drgregpoland)
Host: Halena M. Gazelka, M.D. (@hmgazelkamd)
Each week, the Mayo Clinic Q&A podcast shares the latest information on the COVID-19 pandemic. On today's episode, Dr. Gregory Poland, an infectious diseases expert and head of Mayo Clinic's Vaccine Research Group, answers listeners' coronavirus questions. Topics include: pets and COVID-19, ultraviolet light and viruses, and herd immunity.
AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Wednesday Apr 29, 2020
Mayo Clinic Q&A: The Critical Role of Respiratory Therapists
Wednesday Apr 29, 2020
Wednesday Apr 29, 2020
This episode was recorded in April, 2020.
Guest: Daniel A. Diedrich, M.D.
Host: Halena M. Gazelka, M.D. (@hmgazelkamd)
COVID-19 was first identified late last year with a cluster of pneumonia cases caused by a new coronavirus. The COVID-19 disease process heavily affects the respiratory system, and patients often need oxygen support. The respiratory therapist plays a critical role in managing oxygen levels, placing breathing tubes, and managing the mechanical ventilator, when necessary.
On the Mayo Clinic Q&A podcast, Dr. Daniel Diedrich, a Mayo Clinic anesthesiologist and critical care physician, discusses the role of the respiratory therapist from the time a patient presents with COVID-19 all the way through that patient's discharge.
- AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Wednesday Apr 29, 2020
Wednesday Apr 29, 2020
This episode was recorded on April 22, 2020.
Guest: Rahul Kashyap, M.B.B.S. (@Dr_SRKashyap)
Host: Amit K. Ghosh, M.D., M.B.A. (@AmitGhosh006)
Real time data collection is essential for developing evidence based guidelines when facing emerging pathogens. Dr. Rahul Kashyap discusses VIRUS, a multinational multicenter rapid data collection process and how you can participate.
- Discovery VIRUS COVID-19 Registry (@covid19registry)
https://www.sccm.org/Research/Research/Discovery-Research-Network/VIRUS-COVID-19-Registry - NIH - Viral Infection and Respiratory Illness Universal Study[VIRUS]: COVID-19 Registry (COVID-19) https://clinicaltrials.gov/ct2/show/NCT04323787
- AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Friday Apr 24, 2020
Mayo Clinic Q&A - Keeping Vulnerable Patient Populations Safe
Friday Apr 24, 2020
Friday Apr 24, 2020
This episode is shared from Mayo Clinic Q&A and was recorded in April, 2020.
Guest: Amanda Kubista Owen
Host: Sanjeev (Sanj) Kakar, M.D. (@sanjkakar)
People around the world have been under stay-at-home orders to prevent the spread of coronavirus. While this situation isn't ideal, it can be dangerous for some. For people in abusive situations, home may not be a safe environment.
On the Mayo Clinic Q&A podcast, Amanda Kubista Owen, a Mayo Clinic social worker, discusses services available to help support people affected by domestic violence and why having a safety plan is important.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Thursday Apr 23, 2020
COVID-19 Miniseries Episode 16: Mayo Clinic Q&A - Outbreak Updates
Thursday Apr 23, 2020
Thursday Apr 23, 2020
This episode is shared from Mayo Clinic Q&A and was recorded April 22, 2020.
To claim credit visit: https://ce.mayo.edu/covid19podcast
Guest: Gregory A. Poland, M.D. (@drgregpoland)
Host: Halena M. Gazelka, M.D. (@hmgazelkamd)
On the Mayo Clinic Q&A podcast, Dr. Gregory Poland, an infectious diseases expert and head of Mayo Clinic’s Vaccine Research Group, covers the latest news on the COVID-19 pandemic. Dr. Poland discusses current outbreak numbers, why there may be a second wave of infections, and research on a vaccine.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Wednesday Apr 22, 2020
COVID-19 Miniseries Episode 15: Recommendations for Care of Pregnant Patients
Wednesday Apr 22, 2020
Wednesday Apr 22, 2020
This episode was recorded on April 20, 2020.
To claim credit visit: https://ce.mayo.edu/covid19podcast
Guest: Regan N. Theiler, M.D., Ph.D. (@TheilerRegan)
Host: Amit K. Ghosh, M.D., M.B.A. (@AmitGhosh006)
Does pregnancy itself make a woman more susceptible to COVID-19? What advice should we be giving to pregnant women in the third trimester? How is remote monitoring being utilized? Dr. Regan Theiler discusses how they’re advising and caring for pregnant patients, what’s being reported as potential complications for pregnant patients who’ve been infected with SARS-CoV-2, and what isolation precautions should be applied during and after delivery.
Deeper Dive:
- Mayo Clinic COVID-19 Resources for Providers https://www.mayoclinic.org/medical-professionals/provider-relations/covid-19-resources-for-providers
- Society for Maternal - Fetal Medicine: Clinical Guidance on COVID-19 https://www.smfm.org/covidclinical
- Society for Obstetric Anesthesia and Perinatology - COVID-19 Toolkit https://soap.org/education/provider-education/expert-summaries/interim-considerations-for-obstetric-anesthesia-care-related-to-covid19/
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Wednesday Apr 22, 2020
Mayo Clinic Q&A - Inside Mayo Clinic’s COVID-19 Research Task Force
Wednesday Apr 22, 2020
Wednesday Apr 22, 2020
This episode is shared from Mayo Clinic Q&A and was recorded April, 2020.
Guest: Andrew Badley, M.D. (@BadleyAndrew)
Host: Sanjeev (Sanj) Kakar, M.D. (@sanjkakar)
As the SARS-CoV-2 virus spread worldwide, a race began to develop testing protocols and ramp up research. Mayo Clinic's COVID-19 research task force is studying the virus, predicting hot spots, and working towards effective treatments and a vaccine.
On the Mayo Clinic Q&A podcast, Dr. Andrew Badley, chair of Mayo Clinic’s COVID-19 research task force, gives an update on COVID-19 research activities at Mayo Clinic.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Tuesday Apr 21, 2020
Mayo Clinic Q&A - How Public Health Measures Can Help Reopen the Country
Tuesday Apr 21, 2020
Tuesday Apr 21, 2020
This episode is shared from Mayo Clinic Q&A and was recorded on April 20, 2020.
Guest: Gregory Poland, M.D. (@drgregpoland)
Host: Sanjeev (Sanj) Kakar, M.D. (@sanjkakar)
As the COVID-19 pandemic continues, efforts are underway to find a new normal and begin to re-open the country and the economy. While people are eager for strict social distancing rules to end, public health measures, including testing and tracing for the virus, will be important tools needed to control the spread of the virus and prevent an uptick in new infections.
On the Mayo Clinic Q&A podcast, Dr. Gregory Poland, an infectious diseases expert and head of Mayo Clinic’s Vaccine Research Group, discusses the steps needed to reopen businesses, schools and other activities as the fight to control COVID-19 continues.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Monday Apr 20, 2020
Mayo Clinic Q&A - Serology Testing for SARS-CoV-2 Antibodies
Monday Apr 20, 2020
Monday Apr 20, 2020
This episode is shared from Mayo Clinic Q&A and was recorded April 2020.
Guest: Elitza S. Theel, Ph.D.
Host: Halena M. Gazelka, M.D. (@hmgazelkamd)
A new serology test from Mayo Clinic Laboratories is being used to identify the presence of immune response to SARS-CoV-2, the virus that causes COVID-19. The serology test is intended only to detect antibodies to the virus. It does not diagnose recent or active infection. Mayo Clinic Laboratories also offers a molecular test to diagnose very recent or active infection. Both tests are important tools in the pandemic response.
On the Mayo Clinic Q&A podcast, Dr. Elitza Theel, director of Mayo Clinic’s Infectious Diseases Serology Laboratory, explains why serology testing is initially focused on identifying people in areas where potential immunity is key, including front-line health care workers.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Thursday Apr 16, 2020
Thursday Apr 16, 2020
This episode was recorded on April 15, 2020.
To claim credit visit: https://ce.mayo.edu/covid19podcast
Guest: Alexander S. Niven, M.D. (@niven_alex)
Host: Amit K. Ghosh, M.D., M.B.A. (@AmitGhosh006)
When a patient presents with dyspnea how can we reliably predict who will progress to respiratory failure? How can phenotypes of disease progression be utilized for optimizing selection of treatment modalities? Dr. Alex Niven discusses Fleischner Society recommendations for imaging as a COVID-19 screening tool, cytokine storm, ventilator-associated lung injury, post-ICU care syndrome, and humanity in critical care.
Deeper Dive:
- Mayo Clinic COVID-19 Resources for Providers
https://www.mayoclinic.org/medical-professionals/provider-relations/covid-19-resources-for-providers - Fleischner Society Guidelines
Rubin G, Haramati L, Kanne J, et al. The role of chest imaging in patient management during the COVID-19 pandemic: A multinational consensus statement from the Fleischner Society. Radiology. 2020 April 07; p.201365. https://doi.org/10.1148/radiol.2020201365 - The Berlin Definition
The ARDS Definition Task Force. Acute Respiratory Distress Syndrome: The Berlin Definition. JAMA. 2012;307(23):2526–2533. doi:10.1001/jama.2012.5669
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Monday Apr 13, 2020
COVID-19 Miniseries Episode 13: Mayo Clinic Q&A - Pregnancy and COVID-19
Monday Apr 13, 2020
Monday Apr 13, 2020
This episode is shared from Mayo Clinic Q&A and was recorded in April 2020.
To claim credit visit: https://ce.mayo.edu/covid19podcast
Guest: Nipunie S. Rajapakse, M.D., M.P.H. (@nrajapakseMD)
Host: Sanjeev (Sanj) Kakar, M.D. (@sanjkakar)
How is SARS-CoV-2 affecting pregnant women? Is breastfeeding safe? How can a pregnant woman protect herself from the disease? On the Mayo Clinic Q&A podcast, Dr. Nipunie Rajapakse, a pediatric infectious diseases specialist, will discuss COVID-19 and pregnancy.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Thursday Apr 09, 2020
COVID-19 Miniseries Episode 12: Harnessing Telehealth Without Sacrificing Safety
Thursday Apr 09, 2020
Thursday Apr 09, 2020
This episode was recorded on April 8, 2020.
To claim credit visit: https://ce.mayo.edu/covid19podcast
Guest: Christopher S. Russi, D.O. (@csrussi)
Host: Amit K. Ghosh, M.D., M.B.A. (@AmitGhosh006)
How can telehealth be used to care for COVID-19 patients? How can we leverage telehealth to bring resources to rural facilities? Collaboration through telehealth can provide care where it’s convenient for patients, help offload cognitive burden from colleagues, and mitigate exposure and PPE challenges during this pandemic. Dr. Christopher Russi walks through how the process works and how it’s being leveraged at Mayo Clinic under typical circumstances and how it’s being utilized to triage and inform care for suspected and confirmed COVID-19 patients.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Tuesday Apr 07, 2020
Mayo Clinic Q&A: Medical vs. Public Masking
Tuesday Apr 07, 2020
Tuesday Apr 07, 2020
This episode is shared from Mayo Clinic Q&A and was recorded on Monday, April 6th, 2020.
Guest: Gregory A. Poland, M.D. (@drgregpoland)
Host: Halena M. Gazelka, M.D. (@hmgazelkamd)
To prevent the spread of COVID-19, the Centers for Disease Control and Prevention (CDC) now recommends that Americans wear cloth masks in public settings where other social distancing measures are difficult to maintain. The CDC considers cloth masks an additional, voluntary public health measure.
On the Mayo Clinic Q&A podcast, Dr. Gregory Poland, a Mayo Clinic COVID-19 expert, explains the difference between medical masking and public masking, and discusses the proper way to put a mask on and off to prevent the spread of disease.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
Deeper Dive:

Monday Apr 06, 2020
Monday Apr 06, 2020
This episode is shared from Mayo Clinic Q&A and was recorded on April 3, 2020.
To claim credit visit: https://ce.mayo.edu/covid19podcast
Guest: Gregory A. Poland, M.D. (@drgregpoland)
Host: Halena M. Gazelka, M.D. (@hmgazelkamd)
Dr. Greg Poland returns to share an update on the COVID-19 pandemic in this episode shared from Mayo Clinic Q&A to discuss the latest in antibody testing, coronavirus immunity, and whether or not it’s safe to wear contact lenses.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Friday Apr 03, 2020
Friday Apr 03, 2020
This episode was recorded on April 3, 2020
Claim credit here: https://ce.mayo.edu/covid19podcast
Guest: Michael J. Ackerman, M.D., Ph.D. (@MJAckermanMDPhD)
Host: Amit K. Ghosh, M.D., M.B.A. (@AmitGhosh006)
The administration of hydroxychloroquine and azithromycin, along with other very common medications could result in drug-induced sudden cardiac death caused by drug-induced QT prolongation, in some patients. In order to avoid the wrong medication, for the wrong patient, at the wrong time, Dr. Michael Ackerman shares how to assess your patient’s risk, how to find and measure their QTc value, and neutralize the threat.
Deeper Dive:
- Link to Journal Pre-Proof:
https://mayoclinicproceedings.org/pb/assets/raw/Health%20Advance/journals/jmcp/jmcp_covid19.pdf - Link to COVID-19 QTc Calculator and other resources:
https://www.covidqtc.com/#WRchTxt7-12ve
Giudicessi JR, Noseworthy PA, Friedman PA, Ackerman MJ. Urgent guidance for navigating and circumventing the QTc prolonging and torsadogenic potential of possible pharmacotherapies for COVID-19 [published online ahead of print March 25, 2020]. Mayo Clin Proc. https://doi.org/10.1016/j.mayocp.2020.03.024.
- FDA Emergency Use Authorization (EUA) of hydroxychloroquine sulfate: https://www.fda.gov/media/136538/download
- Mayo Clinic Connected Care - Genetic Heart Rhythm Diseases https://connect.mayoclinic.org/page/genetic-heart-rhythm-disorders/tab/covid-19/#
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Thursday Apr 02, 2020
Mayo Clinic Q&A: The ‘Unprecedented Challenge’ of Fighting COVID-19
Thursday Apr 02, 2020
Thursday Apr 02, 2020
This episode is shared from Mayo Clinic Q&A.
Guest: Elie Berbari, MD (@DODElie)
Host: Tom Shives, MD and Tracy McCray (@TracyMcCray)
The ongoing fight against the COVID-19 pandemic has heavily burdened front-line health care providers. "Our nation and our medical community is facing an unprecedented challenge," says Dr. Elie Berbari, chair of the Division of Infectious Diseases at Mayo Clinic.
On the Mayo Clinic Q&A podcast, Dr. Berbari discusses how Mayo Clinic is minimizing exposure to staff, while providing safe and compassionate care to patients.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Tuesday Mar 31, 2020
Mayo Clinic Q&A: How Does SARS-CoV-2 Make People Sick?
Tuesday Mar 31, 2020
Tuesday Mar 31, 2020
This episode is shared from Mayo Clinic Q&A and was recorded on March 31, 2020.
Guest: Gregory Poland, M.D.
Host: Sanjeev (Sanj) Kakar, M.D. (@sanjkakar)
A novel coronavirus is a new strain that has not been seen before in humans. SARS-Co-V2 is a novel virus, causing the disease COVID-19. Because COVID-19 is a new disease, much is still being learned about how it spreads and the severity of illness it causes.
On the Mayo Clinic Q&A podcast, Dr. Gregory Poland, infectious disease expert and head of Mayo Clinic’s Vaccine Research Group, explains the science behind how the virus makes people sick, and what the virus does to the body. Dr. Poland will also discuss the latest information on clinical trials and vaccine research to fight the disease outbreak.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Monday Mar 30, 2020
COVID-19 Miniseries Episode 9: Recommendations on Ibuprofen
Monday Mar 30, 2020
Monday Mar 30, 2020
This episode was recorded on Monday, March 30, 2020.
Claim credit here: https://ce.mayo.edu/covid19podcast
Guest: Matthew P. Van Cuyk, Pharm.D., R.Ph.
Host: Amit K. Ghosh, M.D., M.B.A. (@AmitGhosh006)
Should we be using ibuprofen to treat patients with COVID-19? Does this fall into the modifiable risk category? Dr. Matthew Van Cuyk breaks down recent events and literature around ibuprofen use in patients with COVID-19.
Deeper Dive:
- Fang L, Karakiulakis G, Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? The Lancet Respiratory Medicine. March 2020. https://doi.org/10.1016/S2213-2600(20)30116-8
- HFSA/ACC/AHA Statement Addresses Concerns Re: Using RAAS Antagonists in COVID-19
- ASHP Coronavirus Resource Center: https://www.ashp.org/Pharmacy-Practice/Resource-Centers/Coronavirus
- Assessment of Evidence for COVID-19-Related Treatments: Updated 3/27/2020
For the most up to date COVID-19 information:

Monday Mar 30, 2020
Mayo Clinic Q&A: Point-of-Care Manufacturing to Help Fight COVID-19
Monday Mar 30, 2020
Monday Mar 30, 2020
This episode is shared from Mayo Clinic Q&A and was recorded on March 26, 2020.
Guest: Jonathan M. Morris, M.D. & Mark Wehde
Host: Tom Shives, MD and Tracy McCray (@TracyMcCray)
When it comes to fighting the COVID-19 pandemic, Mayo Clinic is relying not only on clinicians, but also engineers. Supply chain management and manufacturing capabilities are being readied to help in the fight against COVID-19.
On the Mayo Clinic Q&A podcast, Dr. Jonathan Morris, co-director of Mayo Clinic's 3D Anatomic Modeling Lab, and Mark Wehde, chair of Mayo Clinic's Division of Engineering, discuss personal protective equipment and mobilizing the manufacturing sector to help in the fight. They’ll share how they’re utilizing 3D printing to jump start conventional scalable manufacturing processes to retro-engineer pieces of respiratory equipment and solve today’s problems in the fight against COVID-19.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Friday Mar 27, 2020
COVID-19 Miniseries Episode 8: Azithromycin and Hydroxychloroquine
Friday Mar 27, 2020
Friday Mar 27, 2020
This episode was recorded on March 27, 2020.
To claim credit visit: https://ce.mayo.edu/covid19podcast
Guest: Christina G. Rivera, Pharm.D., R.Ph.; Ryan W. Stevens, Pharm.D. (@Stevens_AK)
Host: Raymund R. Razonable, M.D. (@RazonableMD)
Chloroquine emerged as an early COVID-19 treatment option in China and there has been increasing interest in the use of hydroxychloroquine and azithromycin. What data is available for the safety and efficacy of the drugs in the fight against SARS-CoV-2? Dr. Christina Rivera and Dr. Ryan Stevens provide a breakdown of recent research.
Deeper Dive:
- Gautret P, Lagier JC, Parola P, et al. Hydroxychloroquine and Azithromycin as a treatment of COVID-19: preliminary results of an open-label non-randomized clinical trial. International Journal of Antimicrobial Agents. March 2020. https://doi.org/10.1016/j.ijantimicag.2020.105949
- Yao X, Ye F, Zhang M, et al. In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Clinical Infectious Diseases. March 2020. https://doi.org/10.1093/cid/ciaa237
- Guidance on patients at risk of drug-induced sudden cardiac death from off-label COVID-19 treatments https://mayocl.in/2WQhxzI
For the most up to date COVID-19 information:
- CDC: https://www.cdc.gov/coronavirus/2019-ncov/index.html
- WHO: https://www.who.int/emergencies/diseases/novel-coronavirus-2019
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Thursday Mar 26, 2020
Mayo Clinic Q&A: Shifting from Me to We
Thursday Mar 26, 2020
Thursday Mar 26, 2020
This episode is shared from Mayo Clinic Q&A and was recorded on March 25, 2020.
Guest: Greg Poland, MD (@drgregpoland)
Host: Tom Shives, MD and Tracy McCray (@TracyMcCray)
Greg Poland, MD, answers trending questions from listeners. Is it safe to order take-out or have groceries delivered? Can pets get coronavirus? What about our summer plans? What’s next for social distancing and is it working?
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Wednesday Mar 25, 2020
COVID-19 Miniseries Episode 7: Anosmia - What’s Currently Known
Wednesday Mar 25, 2020
Wednesday Mar 25, 2020
This episode was recorded on March 25, 2020.
Guest: Erin K. O'Brien, M.D. (@ErinOBrienMD)
Host: Amit K. Ghosh, M.D., M.B.A. (@AmitGhosh006)
Claim credit here: https://ce.mayo.edu/covid19podcast
What’s currently known about anosmia as a symptom of COVID-19 infection? Should we be using it as a screening tool? What causes it to occur when someone is infected with SARS-CoV-2 and what’s the prevalence in symptomatic vs otherwise asymptomatic individuals? Dr. Erin O’Brien gives an up-to-date overview of current reports, treatment options, and what you need to know about anosmia.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Tuesday Mar 24, 2020
COVID-19 Miniseries Episode 6: Mayo Clinic Q&A - The Latest Updates
Tuesday Mar 24, 2020
Tuesday Mar 24, 2020
Guest: Greg Poland, MD (@drgregpoland)
Host: Tom Shives, MD and Tracy McCray (@TracyMcCray)
Claim credit for this episode at https://ce.mayo.edu/covid19podcast
On today's Mayo Clinic Q&A podcast, Dr. Gregory Poland, an infectious disease expert and head of Mayo Clinic's Vaccine Research Group, shares the latest information on the COVID-19 pandemic.
Dr. Poland discusses the importance of testing for SARS-CoV-2, work being done on antiviral medications; and how long social distancing might need to last, emerging reports of loss of smell in survivors, and the use of azithromycin and hydroxychloroquine.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Monday Mar 23, 2020
Mayo Clinic Q&A: Coping with Uncertainty
Monday Mar 23, 2020
Monday Mar 23, 2020
This episode is shared from Mayo Clinic Q&A.
Guest: Beth Rush, PhD
Host: Tom Shives, MD and Tracy McCray (@TracyMcCray)
We are in the midst of uncertain times. Dr. Beth Rush, a Mayo Clinic neuropsychologist, shares tips for you and your patients about coping with uncertainty by creating a structured schedule. Listen in as she shares more tips for taking care of your mental health and finding comfort amid the uncertainty.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Friday Mar 20, 2020
Mayo Clinic Q&A: Inflection Point
Friday Mar 20, 2020
Friday Mar 20, 2020
This episode is shared from Mayo Clinic Q&A and was recorded on March 19, 2020.
Guest: Greg Poland, MD
Host: Tom Shives, MD and Tracy McCray
Have we acted sufficiently to flatten the curve? When will we know? What does effective safe isolation look like?
Infectious diseases expert Dr. Gregory Poland, a Mayo Clinic infectious diseases expert and head of Mayo Clinic’s Vaccine Research Group, answers new questions on COVID-19. How are we as a nation faring? What do you do when someone in your house is sick?
Dr. Poland discusses preventive measures to stop the spread of the virus, what to do if you do get sick, and the potential for effective treatments and a vaccine.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.